Paola Zaratin, PhD, Italian Multiple Sclerosis Society, Genoa, Italy, discusses the pivotal role of digital technologies in instigating a paradigm shift for the recognition, monitoring, and treatment of progressive multiple sclerosis (MS). Emphasizing a recent publication in Nature, Dr Zaratin asserts that the optimal use of such technologies should be steered by the firsthand experiences and wisdom of MS patients. By involving the end users—those affected by the disease—technology can transition from being merely a tool to a constructive aid. A prevailing challenge in tracking MS progression is the sporadic assessment during doctor visits; digital technologies offer continuous, real-time monitoring, painting a more comprehensive picture of disease progression. Moreover, advancements in areas like artificial intelligence might yield algorithms capable of predicting the disease’s trajectory. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2023 in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.